Results per Page:
Down to the wire: Shorter timelines make better flu predictions
From the Bedford Lab, Vaccine and Infectious Disease Division
The curious case of ORF8: SARS-CoV-2 evolution is about more than just spike
From the Bedford Lab, Vaccine and Infectious Disease Division
A method to predict how a virus might spread through a population
From the Bedford Lab, Vaccine and Infectious Disease Division
Predicting endemic viruses engaged in an evolutionary battle with the immune system
From the Bedford Lab, Vaccine and Infectious Disease Division
Beyond aesthetics: a visualization tool for better vaccines
From the Bedford lab, Vaccine and Infectious Disease Division
Few variants arise from acute SARS-CoV-2 infections
From the University of Wisconsin-Madison and the Fred Hutch Vaccine and Infectious Disease Division
Seattle Flu Study pivots to SARS-CoV-2
From the University of Washington Medicine and the Fred Hutch Vaccine and Infectious Disease Division
COVID-19: What our scientists are saying
Fred Hutch researchers provide their insights and ideas on the pandemic
COVID-19 detectives are on the case but lack funds
Computational biologists behind Nextstrain seek support for global sequencing work
Genomic surveillance of the Colombian Zika virus outbreak
From the Bedford lab, Vaccine and Infectious Disease Division
Dengue virus evolution drives multiple disease outcomes
From the Bedford lab, Vaccine and Infectious Disease Division
Deep mutational scanning predicts pandemic influenza sequences
From the Bedford and Bloom labs, Vaccine and Infectious Disease and Basic Sciences Divisions
Scanning hemagglutinin to predict the future of flu
From the Bloom Lab, Basic Sciences Division and Bedford Lab, Vaccine and Infectious Disease Division
From camels to humans: this is how MERS do it
From the Bedford laboratory, Vaccine and Infectious Disease Division